Combined cellular and biochemical profiling of Bruton's tyrosine kinase inhibitor nemtabrutinib reveals potential application in MAPK-driven cancers. [PDF]
Kluitmans DJF +8 more
europepmc +1 more source
In Silico Molecular Docking Analysis of Valproic Acid as an Inhibitor of Bruton's Tyrosine Kinase: Potential Drug Repurposing for Allergies. [PDF]
Martinez-Martinez RE +8 more
europepmc +1 more source
Inhibition of bruton's tyrosine kinase directly alleviates pathogenic CD4+ T cell response via PPAR-γ signaling in autoimmune uveitis. [PDF]
Xiao Z +13 more
europepmc +1 more source
Retraction: Bruton's tyrosine kinase inhibition attenuates the cardiac dysfunction caused by cecal ligation and puncture in mice. [PDF]
Frontiers Editorial Office.
europepmc +1 more source
Correction: Ibrutinib, a Bruton's tyrosine kinase inhibitor, exhibits antitumoral activity and induces autophagy in glioblastoma. [PDF]
Wang J +7 more
europepmc +1 more source
The splicing modulator sudemycin induces a specific antitumor response and cooperates with ibrutinib in chronic lymphocytic leukemia [PDF]
Aymerich, Marta +12 more
core +1 more source
Pseudoangiosarcoma and cutaneous collagenous vasculopathy in a patient on a Bruton's tyrosine kinase inhibitor. [PDF]
Kucharik AH +5 more
europepmc +1 more source

